http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101611071-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101611071-B1 |
| titleOfInvention | Composition and method for treating or preventing multiple system atrophy targeting miRNA202 |
| abstract | The present invention discloses pharmaceutical compositions for the prevention or treatment of multi-system atrophy through modulation of microRNA 202. The present disclosure also discloses markers and their uses that can be used in the diagnosis or prognosis measurement of multi-system atrophy. The composition of the present invention may be useful for the treatment of multi-system atrophy by inhibiting oxidative nerve injury by increasing the expression of Oct1. |
| priorityDate | 2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.